An FDA-approved GHRH analogue that reduces excess visceral abdominal fat specifically in adults with HIV-associated lipodystrophy—not a general weight-loss drug.
An FDA-approved GHRH analogue that reduces excess visceral abdominal fat specifically in adults with HIV-associated lipodystrophy—not a general weight-loss drug.